Christopher Cartwright v. HHS - Influenza, lichen planus (2022)
Case summary [AI summaries can sometimes make mistakes]
Christopher Cartwright filed a petition on May 15, 2019, alleging that an influenza vaccine administered on January 10, 2018, caused him to develop lichen planus. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused or significantly aggravated Petitioner's alleged lichen planus or any other injury, and denied that his current condition is a sequela of a vaccine-related injury.
Despite these denials, the parties filed a stipulation on May 31, 2022, recommending an award of compensation. Special Master Nora Beth Dorsey reviewed the stipulation, found it reasonable, and adopted it as the decision of the Court.
Petitioner was awarded $25,000.00 in compensation, payable as a lump sum, for all damages available under the Vaccine Act. The parties agreed to expedite the entry of judgment.
Jessica A. Olins represented the Petitioner, and Nina Ren represented the Respondent.
The public decision does not describe the onset of symptoms, specific medical tests, treatments, or expert witnesses.
Theory of causation
Petitioner Christopher Cartwright alleged that an influenza vaccine administered on January 10, 2018, caused him to develop lichen planus. The respondent denied causation. The parties filed a stipulation recommending compensation, which Special Master Nora Beth Dorsey adopted. Petitioner was awarded $25,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism by which the vaccine allegedly caused the condition.
Source PDFs
USCOURTS-cofc-1_19-vv-00712